Floatz logo

DOTA-FAPI-04 GALLIUM GA-68

Breast Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologySmall moleculeN/AActive
D
26/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
59/ 100

Competitive context

890 Active assets in the Breast Cancer cohort.

Asset / SponsorPhaseRating
Lapatinib
University of New Mexico
Phase 3BBB
Darolutamide
Vandana Abramson
Phase 2BBB
Trastuzumab Duocarmazine
Byondis B.V.
Phase 3BB
ERIBULIN MONOMETHANESULFONATE
Henan Cancer Hospital
Phase 4BB
Palbociclib
Hoffmann-La Roche
Phase 4BB

View all 50 →

Same molecule, other indications

DOTA-FAPI-04 GALLIUM GA-68 is also rated in:

fibrotic liver diseaseDormant
C
Indicative ·
39 / 100
View asset →
Positron Emission TomographyDormant
C
Indicative ·
39 / 100
View asset →
rectal carcinomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →